Quent Long Short Global Small Cap Fund, LP Gilead Sciences, Inc. Transaction History
Quent Long Short Global Small Cap Fund, LP
- $1.16 Billion
- Q4 2025
A detailed history of Quent Long Short Global Small Cap Fund, LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Quent Long Short Global Small Cap Fund, LP holds 3,818 shares of GILD stock, worth $473,775. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,818Holding current value
$473,775% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,406Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Vanguard Group Inc Valley Forge, PA121MShares$15 Billion0.23% of portfolio
-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...